322 related articles for article (PubMed ID: 1722002)
1. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
3. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
4. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
McKinney M; Anderson D; Vella-Rountree L
Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
[TBL] [Abstract][Full Text] [Related]
5. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor.
McKinney M; Miller JH; Aagaard PJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):74-8. PubMed ID: 8423553
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
Messer WS; Ellerbrock B; Price M; Hoss W
Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
9. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
10. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
Mistry R; Dowling MR; Challiss RA
Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
[TBL] [Abstract][Full Text] [Related]
11. Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures.
Ringdahl B
J Pharmacol Exp Ther; 1984 Apr; 229(1):199-206. PubMed ID: 6707935
[TBL] [Abstract][Full Text] [Related]
12. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
Michal P; Lysíková M; Tucek S
Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
[TBL] [Abstract][Full Text] [Related]
14. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
Harden TK; Heng MM; Brown JH
Mol Pharmacol; 1986 Sep; 30(3):200-6. PubMed ID: 3018476
[TBL] [Abstract][Full Text] [Related]
15. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
16. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
17. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
18. Relative potencies of agonists and differential sensitivity to N-ethylmaleimide on muscarinic autoreceptors and postsynaptic receptors in rat hippocampus.
Richards MH
J Pharmacol Exp Ther; 1990 Oct; 255(1):83-9. PubMed ID: 2213574
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
Evans T; Smith MM; Tanner LI; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]